Open-angle glaucoma is linked to an increased risk for early-onset Alzheimer’s disease in middle-aged adults, especially men, ...

Glaucoma is scary for one simple reason, it doesn’t warn you before it starts taking your vision away. Most eye problems give ...

Glaucoma isn’t just an age-related disease. Learn about the risks, symptoms, diagnosis, and treatment options for glaucoma in young adults and why early screening is crucial.

Tirzepatide glaucoma risk was lower than with selective glucagon-like peptide-1 receptor agonists in type 2 diabetes mellitus ...

Their conversation focuses on anatomy-driven, individualized approaches and multidisciplinary decision-making for patients ...

Glaucoma often progresses without symptoms until vision loss is permanent. Experts outline seven early warning signs and ...

Regardless of whether it is a swept-source or spectral-domain platform, OCT angiography is comparably useful for monitoring ...

As Glaucoma Awareness Month highlights the growing burden of the disease, doctors warn that glaucoma remains a leading cause ...

Omidenepag isopropyl led to significant IOP reductions that were sustained over the course of 5 years in patients with ...

What Is Driving the New Fair Value Estimate for Sight Sciences? Sight Sciences now carries a fair value estimate of US$9.35 ...

ViaLase Inc. announced that the first patient has been treated in an investigational device exemption (IDE) clinical trial ...

Shares of Glaukos retreated after the company forecast disappointing sequential revenue growth for its iDose product in the fourth quarter. The stock declined 12% to $97 in after-hours trading on ...